Cargando…

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)

Detalles Bibliográficos
Autores principales: Moon, Jun Sung, Suh, Sunghwan, Kim, Sang Soo, Jin, Heung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831811/
https://www.ncbi.nlm.nih.gov/pubmed/35135079
http://dx.doi.org/10.4093/dmj.2021.0331
_version_ 1784648586153164800
author Moon, Jun Sung
Suh, Sunghwan
Kim, Sang Soo
Jin, Heung Yong
author_facet Moon, Jun Sung
Suh, Sunghwan
Kim, Sang Soo
Jin, Heung Yong
author_sort Moon, Jun Sung
collection PubMed
description
format Online
Article
Text
id pubmed-8831811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-88318112022-02-22 Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83) Moon, Jun Sung Suh, Sunghwan Kim, Sang Soo Jin, Heung Yong Diabetes Metab J Response Korean Diabetes Association 2022-01 2022-01-27 /pmc/articles/PMC8831811/ /pubmed/35135079 http://dx.doi.org/10.4093/dmj.2021.0331 Text en Copyright © 2022 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Response
Moon, Jun Sung
Suh, Sunghwan
Kim, Sang Soo
Jin, Heung Yong
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title_full Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title_fullStr Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title_full_unstemmed Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title_short Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
title_sort efficacy and safety of treatment with quadruple oral hypoglycemic agents in uncontrolled type 2 diabetes mellitus: a multi-center, retrospective, observational study (diabetes metab j 2021;45:675-83)
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831811/
https://www.ncbi.nlm.nih.gov/pubmed/35135079
http://dx.doi.org/10.4093/dmj.2021.0331
work_keys_str_mv AT moonjunsung efficacyandsafetyoftreatmentwithquadrupleoralhypoglycemicagentsinuncontrolledtype2diabetesmellitusamulticenterretrospectiveobservationalstudydiabetesmetabj20214567583
AT suhsunghwan efficacyandsafetyoftreatmentwithquadrupleoralhypoglycemicagentsinuncontrolledtype2diabetesmellitusamulticenterretrospectiveobservationalstudydiabetesmetabj20214567583
AT kimsangsoo efficacyandsafetyoftreatmentwithquadrupleoralhypoglycemicagentsinuncontrolledtype2diabetesmellitusamulticenterretrospectiveobservationalstudydiabetesmetabj20214567583
AT jinheungyong efficacyandsafetyoftreatmentwithquadrupleoralhypoglycemicagentsinuncontrolledtype2diabetesmellitusamulticenterretrospectiveobservationalstudydiabetesmetabj20214567583